TUM Universitätsklinikum - Klinikum rechts der Isar
Research Group: Translational Research Immuno- & Oncology
Ihr Universitätsklinikum im Herzen von München
Prof. Dr. D‘Alessandria’s lab research focus on basic and preclinical radiopharmacy/radiochemistry to develop new peptide and antibody-based radiotheranostic tracers and to bring these new tools in clinical application.
Our mission:
Currently, we do not have any open Postdoc or PhD positions. Applications from talented and motivated postdocs are always welcome. Please send your CV, list of publications and briefly describe your research interests and experience via email to Prof. Dr. D'Alessandria. Postdocs are expected to apply for stipends and fellowships. We will support you in the application process!
We are always looking forward to highly motivated students to conduct internships, Master theses and medical doctoral theses in our lab. If you are interested in an applied, interdisciplinary project, you are self-motivated, curious, organized and willing to spend a few months in the lab, please send a CV and motivation letter to Prof. Dr. D'Alessandria via Email.
Prof. Dr. Calogero D’Alessandria, is Head of Radiochemistry at the Department of Nuclear Medicine of the Technical University of Munich (TUM). Prof. Dr. D’Alessandria graduated and received his PhD in “Physiopathology and Radioisotopical Imaging” at the University “Sapienza” in Rome, Italy. He joined the Department of Nuclear Medicine at TUM in 2007, when he overtook the responsibility of the Radiotherapy Unit.
Prof. Dr. D’Alessandria was trained in Radiopharmacy and Radiochemistry during his research fellows at the Nuclear Medicine Research Laboratory of Imperial Cancer Research Fund (ICRF) of Queen Mary University at St. Bartholomew´s Hospital, London, UK (head Prof. Stephen J. Mather) and at the Institut der Nuklearmedizin Radiologische Chemie Labor Kantonsspital, Basel, Switzerland (Head Prof. Helmut R. Mäcke). Prof. Dr. D’Alessandria’s lab research focus on design, development and validation of bifunctional chelators for Al18F-labeling, 89Zr-labeling, radiolabeled bio-molecules for T cell trafficking and homing visualization, and peptides for tumor detection, with high clinical translation potential, like probes for targeting the tumor microenvironment modulator Galectin-3 and chaperon molecules like Hsp70. He is interested also in targeted radionuclide therapy of cancer using Y-90, Lu-177, Bi-213 and Ac-225 labeled tracers.
Prof. Dr. D’Alessandria has published 53 papers in leading scientific journals including Cancer Research, Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Lancet Oncology, European Urology, Molecular Imaging and Biology and Theranostics.
Prof Dr. Calogero D’Alessandria Adjunct Teaching Professor, Director of Radiochemistry & Radiopharmacy | Dr. Francesco De Rose |
Dr. Antonia Richter | Dr. Petra Watzlowik |
Dr. Lisa Russelli | Adriano Bolognani |
Michael Herz |
